Experience Sonic like never before! In search of the missing Chaos Emeralds, Sonic becomes stranded on an ancient island teeming with unusual creatures. Accelerate to new heights and explore vast open ...

BloodRayne: Definitive Collection will launch for PlayStation 5 and Switch on July 29, publisher Strictly Limited Games and developer Ziggurat Interactive announced. It includes BloodRayne: Revamped, ...

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. Ubisoft’s The Division is getting a definitive edition, it appears.

Sega is pointing to consumer expectations for “definitive editions” as one potential cause behind lower-than-expected sales for some of its recent games. As spotted by GameBiz, the Sonic the Hedgehog ...

Joe Grantham is a contributor from the UK with a degree in Classical Studies. His love for gaming is only rivaled by a deep passion for medieval history, which often seeps into his articles. With over ...

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. Mortal Kombat 1: Definitive Edition has been announced by its ...

Get over here because Mortal Kombat 1: Definitive Edition launches today, allowing you to grab everything NetherRealm Studios’ latest fighting game has to offer in one package. For $69.99, Mortal ...

For over 5 years, Arthur has been professionally covering video games, writing guides and walkthroughs. His passion for video games began at age 10 in 2010 when he first played Gothic, an immersive ...

A creatine loading phase is when a person takes a higher dose than the maintenance level for several days. Proponents suggest this saturates the muscles with creatine, allowing people to experience ...

In an era where open-world games are a dime a dozen, Xenoblade Chronicles X soars above the pack. There’s an unparalleled feeling of freedom and exploration as you fly your mech suit across the ...

A phase 1b, open-label, multicenter study of xaluritamig in patients with newly diagnosed localized intermediate- or high-risk prostate cancer in the neoadjuvant setting. This is an ASCO Meeting ...